Клинические рекомендации: запоры у взрослых


DOI: https://dx.doi.org/10.18565/therapy.2020.4.77-101

Разработаны Российским научным медицинским обществом терапевтов (РНМОТ) и Научным обществом гастроэнтерологов России (НОГР), 2019
Ключевые слова: хронический запор, диагностика запора, немедикаментозное лечение запора, медикаментозное лечение запора
Полный текст статьи доступен
в "Библиотеке Врача"

Литература


  1. Drossman D.A. Hasler W.L. Rome IV – functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016; 150(6): 1257–61. doi: 10.1053/j.gastro.2016.03.035.

  2. Парфенов А.И., Индейкина Л.Х., Беляева А.А. с соавт. Хронический запор. Методические рекомендации. Москва. 2016; 54 с.

  3. Bharucha A.E., Dorn S.D., Lembo A., Pressman A. American Gastroenterological Association medical position statement on constipation. Gastroenterology. 2013; 144(1): 211–17. doi: 10.1053/j.gastro.2012.10.029.

  4. Dukas L., Willett W.C., Giovannucci E.L. Association between physical activity, fiber intake, and other lifestyle variables and constipation in a study of women. Am J Gastroenterol. 2003; 98: 1790–96. doi: 10.1111/j.1572-0241.2003.07591.x.

  5. Chu H., Zhong L., Li H. et al. Epidemiology characteristics of constipation for general population, pediatric population, and elderly population in China. Gastroenterol Res Pract. 2014; 2014: 532734. doi: 10.1155/2014/532734.

  6. Vazquez Roque M., Bouras E.P. Epidemiology and management of chronic constipation in elderly patients. Clin Interv Aging. 2015; 10: 919–30. doi: 10.2147/CIA.S54304.

  7. Enck P., Leinert J., Smid M. et al. Prevalence of constipation in the German population – a representative survey (GECCO). United European Gastroenterol J. 2016; 4(3): 429–37. doi: 10.1177/2050640615603009.

  8. Wald A., Scarpignato C., Mueller-Lissner S. et al. A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation. Aliment Pharmacol Ther. 2008; 28(7): 917–30. doi: 10.1111/j.1365-2036.2008.03806.x.

  9. Лазебник Л.Б., Прилепская С.И., Барышникова Е.Н. с соавт. Распространенность и факторы риска запоров у взрослого населения Москвы (по данным популяционного исследования «МУЗА». Экспериментальная и клиническая гастроэнтерология. 2011; 3: 68–73.

  10. Bharucha A.E. Constipation. Best Pract Res Clin Gastroenterol. 2007; 21(4):709–31. doi: 10.1016/j.bpg.2007.07.001.

  11. Bassotti G., Bellini M., Pucciani F. et al. Italian Constipation Study Group. An extended assessment of bowel habits in a general population. World J Gastroenterol. 2004; 10: 713–16. doi: 10.3748/wjg.v10.i5.713.

  12. Branch R.L., Butt T.F. Drug-induced constipation. Adv Drug Reaction Bull. 2009; 257: 987–90.

  13. Tack J., Muller-Lissner S., Stanghellini V. et al. Diagnosis and treatment of chronic constipation – a European perspective. Neurogastroenterol Motil. 2011; 23(8):697–710. doi: 10.1111/j.1365-2982.2011.01709.x.

  14. Enck P., Leinert J., Menno Smid M. et al. Somatic comorbidity in chronic constipation: more data from the GECCO study. United European Gastroenterol J. 2016; 4(1): 142–51. doi: 10.1177/2050640614558476.

  15. Choung R.S, Rey E., Locke III G.R. et al. Chronic constipation and co-morbidities: A prospective population-based nested case-control study. United European Gastroenterology Journal. 2016; 4(1): 142–51. doi: 10.1177/2050640614558476.

  16. Talley N.J. How to do and interpret a rectal examination in gastroenterology. Am J Gastroenterol. 2008; 103(4): 820–22. doi: 10.1111/j.1572-0241.2008.01832.x.

  17. Jamshed N., Lee Z.-E., Olden K.W. Diagnostic approach to chronic constipation in adults. Am Fam Physician. 2011; 84(3): 299–306.

  18. Стандарт медицинской помощи больным с болезнью Гиршпрунга (при оказании специализированной помощи). Утвержден Приказом Миздравсоцразвития России от 29 мая 2007 г. № 362.

  19. Стандарт медицинской помощи больным с болезнью Гиршпрунга. Утвержден Приказом Миздравсоцразвития России от 9 февраля 2006 года № 73.

  20. Стандарт медицинской помощи больным мегаколоном. Утвержден Приказом Миздравсоцразвития России от 9 февраля 2006 года № 67.

  21. Gao R., Tao Y., Zhou C. et al. Exercise therapy in patients with constipation: a systematic review and meta-analysis of randomized controlled trials. Scand J Gastroenterol. 2019; 54(2): 169–77. doi: 10.1080/00365521.2019.1568544.

  22. Walter S.C., Correa Neto I.J.F., Pinto R.A. et al. Diagnosis and treatment of constipation: a clinical update based on the Rome IV criteria. J Coloproctol (Rio J). 2018; 38(2): 137–44.

  23. Lee-Robichaud H., Thomas K., Morgan J., Nelson R.L. Lactulose versus polyethylene glycol for chronic constipation. Cochrane Database Syst Rev. 2010; 7: CD007570. doi: 10.1002/14651858.CD007570.pub2.

  24. Fleming V., Wade W.E. A review of laxative therapies for treatment of chronic constipation in older adults. Am J Geriatr Pharmacother. 2010; 8(6): 514–50. doi: 10.1016/S1543-5946(10)80003-0.

  25. Marlett J., Kajs T., Fischer M. An unfermented gel component of psyllium seed husk promotes laxation as a lubricant in humans. Am J Clin Nutr. 2000; 72: 784–89. doi: 10.1093/ajcn/72.3.784.

  26. Ford A.C., Suares N.C. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut. 2011; 60: 209–18. doi: 10.1136/gut.2010.227132.

  27. Anti M., Pignataro G., Armuzzi A. et al. Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation. Hepatogastroenterology. 1998; 45:727–32.

  28. Lee-Robichaud H., Thomas K., Morgan J., Nelson R.L. Lactulose versus polyethylene glycol for chronic constipation. Cochrane Database Syst Rev. 2010; 7: CD007570. doi: 10.1002/14651858.CD007570.pub2.

  29. Suares N.C., Ford A.C. Systematic review: the effects of fibre in the management of chronic idiopathic constipation. Aliment Pharmacol Ther. 2011; 33: 895–90. doi: 10.1111/j.1365-2036.2011.04602.x.

  30. Ford A., Moayyedi P., Lacy B.E. et al. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol. 2014;109 Suppl 1: S2–26; quiz S27. doi: 10.1038/ajg.2014.187.

  31. Chmielewska A., Szajewska H. Systematic review of randomized controlled trials: probiotics for functional constipation. World J Gastroenterol. 2010; 16(1): 69–75. doi: 10.3748/wjg.v16.i1.69.

  32. Ojetti V., Ianiro G., Tortora A. et al. The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial. J Gastrointestin Liver Dis. 2014; 23: 387–91. doi: 10.15403/jgld.2014.1121.234.elr.

  33. Quigley Eamonn M.M. Prucalopride: safety, efficacy and potential applications. Ther Adv Gastroenterol. 2012; 5(1) 23–30. doi: 10.1177/1756283X11423706.

  34. Зароднюк И.В. Рентгенологическая дефекография в обследовании колопроктологических больных. Радиология – практика. 2004; 2: 26–30.

  35. Левин М.Д., Дегтярев Ю.Г., Аверин В.И. с соавт. Стандартизация рентгенологического исследования толстой кишки и аноректальной зоны. Новости хирургии. 2013; 4: 90–98.

  36. Paquette I.M., Madhulika V., Charles T. et al. The American Society of Colon and Rectal Surgeons’ clinical practice guideline for the evaluation and management of constipation. Dis Colon Rectum. 2016; 59(6): 479–92. doi: 10.1097/DCR.0000000000000599.

  37. Southwell B.R., Clarke M.C., Sutcliffe J., Hutson J.M. Colonic transit studies: Normal values for adults and children with comparison of radiological and scintigraphic methods. Pediatr Surg Int. 2009; 25(7): 559–72. doi: 10.1007/s00383-009-2387-x.

  38. Sleisenger M.H., Feldman M., Friedman L.S., Brandt LJ. Sleisenger & Fordtran’s gastrointestinal and liver disease: pathophysiology, diagnosis, management. 8th ed. Philadelphia: Saunders. 2006; pp. 2127–46.

  39. Парфенов А.И. Энтерология. Триада-Х. 2002; 744 с.

  40. Шемеровский К.А. Хронопатологические аспекты моторно-эвакуаторной функции пищеварительного тракта. Глава 19. Хронобиология и хрономедицина: руководство. Под ред. С.И. Рапопорта, В.А. Фролова, Л.Г. Хетагуровой. М.: Медицинское информационное агентство. 2012; 480 с.

  41. Sleisenger M.H., Feldman M., Friedman L.S., Brandt LJ. Sleisenger & Fordtran’s gastrointestinal and liver disease: pathophysiology, diagnosis, management. 8th ed. Philadelphia: Saunders. 2006; pp. 2127–46.

  42. Phillips L.K., Rayner C.K., Jones K.L., Horowitz M. An update on autonomic neuropathy affecting the gastrointestinal tract. Curr Diab Rep. 2006; 6: 417–23. doi: 10.1007/s11892-006-0073-0.

  43. Forgacs I., Patel V. Diabetes and the gastrointestinal tract. Medicine. 2011; 39: 288–92.

  44. Krishnan B., Babu S., Walker J. et al. Gastrointestinal complications of diabetes mellitus. World J Diabetes. 2013; 4(3): 51–63. doi: 10.4239/wjd.v4.i3.51

  45. Chandrasekharan B., Anitha M., Blatt R. et al. Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress. Neurogastroenterol Motil. 2011; 23(2): 131–38, e26. doi: 10.1111/j.1365-2982.2010.01611.x.

  46. Maisey A. A practical approach to gastrointestinal complications of diabetes. Diabetes Ther. 2016; 7(3): 379–86. doi: 10.1007/s13300-016-0182-y.

  47. Ihana-Sugiyama N., Nagata N., Yamamoto-Honda R. et al. Constipation, hard stools, fecal urgency, and incomplete evacuation, but not diarrhea is associated with diabetes and its related factors. World J Gastroenterol. 2016; 22(11): 3252–60. doi: 10.3748/wjg.v22.i11.3252.

  48. Choung R.S, Rey E., Locke III G.R. et al. Chronic constipation and co-morbidities: A prospective population-based nested case-control study. United European Gastroenterology Journal. 2016; 4(1): 142–51. doi: 10.1177/2050640614558476.

  49. Pustorino S., Foti M., Calipari G. et al.

  50. Ebert E.C. The thyroid and the gut. J Clin Gastroenterol. 2010; 44(6): 402–06. doi: 10.1097/MCG.0b013e3181d6bc3e.

  51. Tenore A., Fasano A., Gasparini N. et al. Thyroxine effects on intestinal Cl-HCO3-exchange in hypo- and hyperthyroid rats. J Endocrinol. 1996: 151: 431. doi: 10.1677/joe.0.1510431.

  52. Abbasi A.A., Douglass R.C., Bissel G.W., Chen Y. Myxedema ileus. A form of intestinal pseudo-obstruction. JAMA. 1975; 234(2): 181–83. doi: 10.1001/jama.234.2.181.

  53. Koksal A.R., Ergun M., Boga S. et al. Increased prevalence of colorectal polyp in acromegaly patients: a case-control study. Diagn Ther Endosc. 2014; 2014: 152049. doi: 10.1155/2014/152049.

  54. Rokkas T., Pistiolas D., Sechopoulos P. et al. Risk of colorectal neoplasm in patients with acromegaly: a meta‑analysis. World J Gastroenterol. 2008; 14(22): 3484–89. doi: 10.3748/wjg.14.3484.

  55. Wassenaar M.J., Cazemier M., Biermasz N.R. et al. Acromegaly is associated with an increased prevalence of colonic diverticula: a case-control study. J Clin Endocrinol Metab. 2010; 95(5): 2073–79. doi: 10.1210/jc.2009-1714.

  56. Renehan A.G., Painter J.E., Bell G.D. et al. Determination of large bowel length and loop complexity in patients with acromegaly undergoing screening colonoscopy. Clin Endocrinol (Oxf). 2005; 62: 323–30. doi: 10.1111/j.1365-2265.2005.02217.x.

  57. Zhao L., Liu J.-M., He X.-Y. et al. The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center. J Clin Endocrinol Metab. 2013; 98(2): 721–28. doi: 10.1210/jc.2012-2914..

  58. Bargren A.E., Repplinger D., Chen H., Sippel R.S. Can biochemical abnormalities predict symptomatology in patients with primary hyperparathyroidism? J. Am. Coll. Surg. 2011; 213(3): 410–14. doi: 10.1016/j.jamcollsurg.2011.06.401.

  59. de Oliveira S.C., Pinto-Neto A.M., Goes J.R. et al.

  60. Oh J.-E., Kim Y.-W., Park S.-Y., Kim J.-Y. Estrogen rather than progesterone cause constipation in both female and male mice. Korean J Physiol Pharmacol. 2013; 17(5): 423–26. doi: 10.4196/kjpp.2013.17.5.423.

  61. Bassotti G., Villanacci V., Bellomi A. et al. An assessment of enteric nervous system and estroprogestinic receptors in obstructed defecation associated with rectal intussusception. Neurogastroenterol Motil. 2012; 24(3): e155–61. doi: 10.1111/j.1365-2982.2011.01850.x.

  62. Coggrave M., Norton C., Cody J.D. Management of fecal incontinence and constipation in adults with central neurological diseases. Cochrane Database Syst Rev. 2014; 1: CD002115. doi: 10.1002/14651858.CD002115.pub5.

  63. Jost W.H. Gastrointestinal motility problems in patients with Parkinson’s disease. Effects of antiparkinsonian treatment and guidelines for management. Drugs Aging. 1997; 10: 249–58. doi: 10.2165/00002512-199710040-00002.

  64. Norton C., Chelvanayagam S. Bowel problems and coping strategies in people with multiple sclerosis. Br J Nurs. 2010; 19(4): 220, 221–26. doi: 10.12968/bjon.2010.19.4.46783.

  65. Nusrat S., Gulick E., Levinthal D., Bielefeldt K. Anorectal dysfunction in multiple sclerosis: a systematic review. ISRN Neurol. 2012; 2012: 376023. doi: 10.5402/2012/376023.

  66. Collins P., Rhodes J. Ulcerative colitis: diagnosis and management. BMJ. 2006; 333(7563): 340–43. doi: 10.1136/bmj.333.7563.340.

  67. Fargo M.V., Latimer K.M. Evaluation and management of common anorectal conditions. Am Fam Physician. 2012; 85(6): 624–30.

  68. Salmoirago-Blotcher E., Crawford S., Jackson E. et al. Constipation and risk of cardiovascular disease among postmenopausal women. Am J Med. 2011; 124(8): 714–23. doi:10.1016/j.amjmed.2011.0

  69. Honkura K., Tomata Y., Sugiyama K. et al. Defecation frequency and cardiovascular disease mortality in Japan: The Ohsaki cohort study. Atherosclerosis. 2016; 246: 251–56. doi: 10.1016/j.atherosclerosis.2016.01.007.

  70. Bassotti G. Being constipated: A bad omen for your cardiovascular system? Atherosclerosis. 2016; 245: 240–41. doi: 10.1016/j.atherosclerosis.2015.10.001.

  71. Ma W., Li Y., Heianza Y. et al. Associations of bowel movement frequency with risk of cardiovascular disease and mortality among US women. Sci Rep. 2016; 6: 33005. doi: 10.1038/srep33005.

  72. Markland А., Dunivan G,. Vaughan C. et al. Anal intercourse and fecal incontinence: evidence from the 2009–2010 National Health and Nutrition Examination Survey. Am J Gastroenterol. 2016; 111(2): 269–74. doi: 10.1038/ajg.2015.419.

  73. Locke G.R., Pemberton J.H., Phillips S.F. AGA technical review on constipation: American Gastroenterological Association. Gastroentrology. 2000; 119(6): 1766–78. doi: 10.1053/gast.2000.20392.

  74. Talley N.J., Fleming K.C., Evans J.M. et al. Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol. 1996; 91(1): 19–25.

  75. Talley N.J., Jones M., Nuyts G. et al. Risk factors for chronic constipation based on a general practice sample. Am J Gastroenterol. 2003; 98: 1107–11. doi: 10.1111/j.1572-0241.2003.07465.x.

  76. Клинические рекомендации «Подготовка пациентов к эндоскопическому исследованию толстой кишки». Российское эндоскопическое общество. Москва. 2017; 69 с.

  77. Huffman M., Zackary Unger R., Thatikonda C. et al. Split-dose bowel preparation for colonoscopy and residual gastric fluid volume: an observational study. Gastrointest Endosc. 2010; 72(3): 516–22. doi: 10.1016/j.gie.2010.03.1125.

  78. Mohamed R., Hilsden R.J., Dube C., Rostom A. Split-dose polyethylene glycol is superior to single dose for colonoscopy preparation: results of a randomized controlled trial. Can J Gastroenterol Hepatol. 2016; 2016: 3181459. doi: 10.1155/2016/3181459.

  79. Kilgore T.W., Abdinoor A.A., Szary N.M. et al. Bowel preparation with split-dose polyethylene glycol before colonoscopy: a meta-analysis of randomized controlled trials. Gastrointest Endosc. 2011; 73(6): 1240–45. doi: 10.1016/j.gie.2011.02.007.

  80. Enestvedt B.K., Tofani C., Laine L.A. et al. 4-liter split-dose polyethylene glycol is superior to other bowel preparations, based on systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2012; 10(11): 1225–31. doi: 10.1016/j.cgh.2012.08.029.

  81. Hassan C., East J., Radaelli F. et al. Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) guideline – update 2019. Endoscopy. 2019; 51(8): 775–94. doi: 10.1055/a-0959-0505.

  82. Rex D.K., Di Palma J.A., Rodriguez R. et al. A randomized clinical study comparing reduced-volume oral sulfate solution with standard 4-liter sulfate-free electrolyte lavage solution as preparation for colonoscopy . Gastrointest Endosc. 2010; 72(2): 328–36. doi: 10.1016/j.gie.2010.03.1054.

  83. Kaminski M.F., Thomas-Gibson S., Bugajski M. et al. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy. 2017; 49(4): 378–97. doi: 10.1055/s-0043-103411.

  84. Ishiyama Y., Hoshide S., Mizuno H., Kario K. Constipationinduced pressor effects as triggers for cardiovascular events. J Clin Hypertens. 2019; 21(5): 421–25. doi: 10.1111/jch.13489.

  85. Pedrosa Carrasco A.J., Timmermann L., Pedrosa D.J. Management of constipation in patients with Parkinson’s disease. NPJ Parkinson’s Disease. 2018; 4: 6. doi: 10.1038/s41531-018-0042-8.

  86. Yan M., Zhang L.-Y., Sun L.-X. et al. Nephrotoxicity study of total rhubarb anthraquinones on Sprague Dawley rats using DNA microarrays. J Ethnopharmacol. 2006; 107(2): 308–11. doi: 10.1016/j.jep.2006.03.031.

  87. Noureddin S., Mohsen J., Payman A. Effects of psyllium vs. placebo on constipation, weight, glycemia, and lipids: A randomized trial in patients with type 2 diabetes and chronic constipation. Complementary Therapies in Medicine. 2018; 40: 1–7. doi: 10.1016/j.ctim.2018.07.004.

  88. Чернусь Н.П., Ванчакова Н.П., Сивкова С.К. с соавт. Ипидакрин в комбинированных схемах лечения функционального запора. Терапевтический архив. 2018; 12: 48–55.


Об авторах / Для корреспонденции

Леонид Борисович Лазебник, д.м.н., профессор, профессор кафедры поликлинической терапии ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава России, президент Научного общества гастроэнтерологов России, вице-президент Российского научного медицинского общества терапевтов, член президиума Общества врачей России, член президиума Национальной медицинской палаты. Адрес: 127473, г. Москва, Делегатская ул., д. 20, стр. 1. Тел.: 8 (985) 920-83-42. E-mail: leonid.borisl@gmail.com

К содержанию номера

Бионика Медиа